Inovio Pharmaceuticals Inc INO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/18/24 EDT
10.20quote price arrow down-0.87 (-7.86%)
Volume
391,876
52 week range
3.89 - 14.75
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close10.20
  • 52 Week High14.75
  • 52 Week High Date04/01/24
  • 52 Week Low3.89
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap238.378M
  • Shares Out23.37M
  • 10 Day Average Volume0.37M
  • Dividend-
  • Dividend Yield-
  • Beta1.17
  • YTD % Change66.67

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close10.20
  • 52 Week High14.75
  • 52 Week High Date04/01/24
  • 52 Week Low3.89
  • 52 Week Low Date11/10/23
  • Market Cap238.378M
  • Shares Out23.37M
  • 10 Day Average Volume0.37M
  • Dividend-
  • Dividend Yield-
  • Beta1.17
  • YTD % Change66.67

RATIOS/PROFITABILITY

  • EPS (TTM)-6.15
  • P/E (TTM)-1.66
  • Fwd P/E (NTM)-2.59
  • EBITDA (TTM)-128.66M
  • ROE (TTM)-79.55%
  • Revenue (TTM)832,009.971
  • Gross Margin (TTM)-
  • Net Margin (TTM)-16,239.87%
  • Debt To Equity (MRQ)14.29%

EVENTS

  • Earnings Date05/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Inovio Pharmaceuticals Inc

 

Profile

MORE
Inovio Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing deoxyribonucleic acid (DNA) medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines pipeline include INO-3107 for HPV-related recurrent respiratory papillomatosis (RRP); INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma, or...
Simon Benito
Independent Chairman of the Board
Jacqueline Shea Ph.D.
President, Chief Executive Officer, Director
Peter Kies
Chief Financial Officer
Address
6769 Mesa Ridge Rd.
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
RGLS
Regulus Therapeutics Inc
2.22-0.12-5.13%
INMB
INmune Bio Inc
8.80+0.37+4.39%
ACET
Adicet Bio Inc
2.02-0.24-10.79%
LENZ
LENZ Therapeutics Inc
17.49-0.21-1.19%
CADL
Candel Therapeutics Inc
5.46+0.02+0.37%